Abbott Laboratories is a global healthcare company that develops, manufactures, and sells a broad range of healthcare products, including medical devices, nutritionals, and pharmaceuticals.
This financial article details a specific bond issuance from Abbott, a globally recognized diversified healthcare company renowned for its broad portfolio encompassing diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals, significantly contributing to global health. Identified by ISIN US002824BJ81 and CUSIP 002824BJ8, this security was issued in the United States and denominated in US Dollars (USD). The bond featured a fixed coupon interest rate of 2%, with interest payments distributed semi-annually. With a total issue size amounting to $473,770,000 and a minimum purchase size set at $1,000, this instrument represented a substantial component of Abbott's funding structure. The bond reached its scheduled maturity on September 15, 2018, and was subsequently redeemed at its par value of 100%, completing its lifecycle and returning the principal to its bondholders as per its terms.
|
Français
Italiano
United States
US002824BJ81 ( in USD )
